GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Price-to-Owner-Earnings

3SBio (TRSBF) Price-to-Owner-Earnings : 11.43 (As of May. 01, 2024)


View and export this data going back to 2018. Start your Free Trial

What is 3SBio Price-to-Owner-Earnings?

As of today (2024-05-01), 3SBio's share price is $0.80. 3SBio's Owner Earnings per Share (TTM) ended in Dec. 2023 was $0.07. It's Price-to-Owner-Earnings for today is 11.43.


The historical rank and industry rank for 3SBio's Price-to-Owner-Earnings or its related term are showing as below:

TRSBF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.27   Med: 26.85   Max: 52.66
Current: 11.46

During the past 10 years, the highest Price-to-Owner-Earnings of 3SBio was 52.66. The lowest was 8.27. And the median was 26.85.


TRSBF's Price-to-Owner-Earnings is ranked better than
82.42% of 165 companies
in the Biotechnology industry
Industry Median: 32.2 vs TRSBF: 11.46

As of today (2024-05-01), 3SBio's share price is $0.80. 3SBio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.09. Therefore, 3SBio's PE Ratio for today is 9.30.

As of today (2024-05-01), 3SBio's share price is $0.80. 3SBio's EPS without NRI for the trailing twelve months (TTM) ended in was $0.10. Therefore, 3SBio's PE Ratio without NRI for today is 7.92.

During the past 10 years, 3SBio's highest PE Ratio without NRI was 59.56. The lowest was 6.31. And the median was 24.50.


3SBio Price-to-Owner-Earnings Historical Data

The historical data trend for 3SBio's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Price-to-Owner-Earnings Chart

3SBio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.89 28.60 11.43 11.43 13.33

3SBio Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.43 - 11.43 - 13.33

Competitive Comparison of 3SBio's Price-to-Owner-Earnings

For the Biotechnology subindustry, 3SBio's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where 3SBio's Price-to-Owner-Earnings falls into.



3SBio Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

3SBio's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.80/0.07
=11.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio  (OTCPK:TRSBF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


3SBio Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of 3SBio's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio (TRSBF) Business Description

Traded in Other Exchanges
Address
No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027
3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines